Non-Alcoholic Fatty Liver Disease Clinical Trials

• Capable of giving signed informed consent prior to the performance of any study-specific procedures.

• Able and willing to comply with all study assessments and adhere to the protocol schedule of activities.

• In the opinion of the investigator, there is a history of alcohol consumption compatible with either ALD or Met ALD.

• A female participant is eligible to participate after meeting additional pre-defined criteria.

• Participants must meet predefined stable use requirements of concomitant medications based on study criteria.

• Participant has advanced chronic liver disease